Inside CIDP Treatment: What Pharmacists Need to Know (CE)

Claire Spahn, PharmD, MS, BCPS is a clinical pharmacist at Stanford Health Care in Stanford, California. Dr. Spahn received her BS(Pharm degree from Trinity College, Dublin, Ireland, her PharmD degree from Western University of Health Sciences in Los Angeles and an MS degree from University of Florida. She completed a PGY1 acute care pharmacy residency at Stanford Health Care, Stanford California. Dr. Spahn practices in specialty ambulatory care clinics including neurology and pharmacogenomics.

Neelam Goyal, MD is a Clinical Professor of Neurology and Neurological Sciences in the division of Neuromuscular Medicine. She earned her medical degree at SUNY Downstate in Brooklyn, NY. Subsequently, she completed her neurology residency, which included a chief year, followed by a fellowship year in neurophysiology, specializing in neuromuscular disorders and EMG nerve conduction studies at Stanford University Medical Hospital. Dr. Goyal focuses on the diagnosis, management, and electrophysiological testing of neuromuscular disorders, including SFEMG. Her expertise extends to immune-mediated disorders such as myositis, myasthenia gravis, CIDP, and vasculitis. Her research interests involve monitoring and managing the short and long-term toxicity of immunosuppressive agents. She is actively involved in a grant-supported project investigating steroid toxicity in patients with myasthenia gravis.

Relevant Financial Relationship Disclosures

The following person in control of this activity’s content has relevant financial relationships: 

• Neelam Goyal: Principal Investigator and Advisor – argenx

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

Expiration Date

This CE activity expires on February 26, 2027 

LISTEN ON